325 related articles for article (PubMed ID: 8608781)
21. Monitoring differentiated thyroid cancer patients with negative serum thyroglobulin. Diagnostic implication of TSH-stimulated antithyroglobulin antibody.
Nam HY; Paeng JC; Chung JK; Kang KW; Cheon GJ; Kim Y; Park DJ; Park YJ; Min HS; Lee DS
Nuklearmedizin; 2014; 53(2):32-8. PubMed ID: 24276613
[TBL] [Abstract][Full Text] [Related]
22. Clinical review: Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC).
Spencer CA
J Clin Endocrinol Metab; 2011 Dec; 96(12):3615-27. PubMed ID: 21917876
[TBL] [Abstract][Full Text] [Related]
23. Clinical relevance of highly sensitive Tg assay in monitoring patients treated for differentiated thyroid cancer.
Iervasi A; Iervasi G; Ferdeghini M; Solimeo C; Bottoni A; Rossi L; Colato C; Zucchelli GC
Clin Endocrinol (Oxf); 2007 Sep; 67(3):434-41. PubMed ID: 17555505
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic value of serum thyroglobulin measurements in the follow-up of differentiated thyroid carcinoma, a structured meta-analysis.
Eustatia-Rutten CF; Smit JW; Romijn JA; van der Kleij-Corssmit EP; Pereira AM; Stokkel MP; Kievit J
Clin Endocrinol (Oxf); 2004 Jul; 61(1):61-74. PubMed ID: 15212646
[TBL] [Abstract][Full Text] [Related]
25. Thyroglobulin: current aspects of its role in autoimmune thyroid disease and thyroid cancer.
Okosieme OE; Parkes AB; Premawardhana LD; Evans C; Lazarus JH
Minerva Med; 2003 Oct; 94(5):319-30. PubMed ID: 14973426
[TBL] [Abstract][Full Text] [Related]
26. [Differentiated thyroid carcinoma--how to improve the long-term results? Twenty-five-year outcomes of 850 patients].
Melliere D; Hindie E; Becquemin JP; Desgranges P; Allaire E; Geachan E
Bull Acad Natl Med; 2006 Jan; 190(1):89-106; discussion 106-9. PubMed ID: 16878448
[TBL] [Abstract][Full Text] [Related]
27. Serum thyroglobulin (Tg) monitoring of patients with differentiated thyroid cancer using sensitive (second-generation) immunometric assays can be disrupted by false-negative and false-positive serum thyroglobulin autoantibody misclassifications.
Spencer C; Petrovic I; Fatemi S; LoPresti J
J Clin Endocrinol Metab; 2014 Dec; 99(12):4589-99. PubMed ID: 25226290
[TBL] [Abstract][Full Text] [Related]
28. Discordance in thyroglobulin measurements by radioimmunoassay and immunometric assay: a useful means of identifying thyroglobulin assay interference.
Crane MS; Strachan MW; Toft AD; Beckett GJ
Ann Clin Biochem; 2013 Sep; 50(Pt 5):421-32. PubMed ID: 23847033
[TBL] [Abstract][Full Text] [Related]
29. Discordant serum thyroglobulin results generated by two classes of assay in patients with thyroid carcinoma: correlation with clinical outcome after 3 years of follow-up.
Weightman DR; Mallick UK; Fenwick JD; Perros P
Cancer; 2003 Jul; 98(1):41-7. PubMed ID: 12833453
[TBL] [Abstract][Full Text] [Related]
30. Utility of third generation thyrotropin assays in thyroid function testing.
Saller B; Broda N; Heydarian R; Görges R; Mann K
Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 4():S29-33. PubMed ID: 9867193
[TBL] [Abstract][Full Text] [Related]
31. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.
Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882
[TBL] [Abstract][Full Text] [Related]
32. Real time RT-PCR analysis of thyroglobulin mRNA in peripheral blood in patients with congenital athyreosis and with differentiated thyroid carcinoma after stimulation with recombinant human thyrotropin.
Kaufmann S; Schmutzler C; Schomburg L; Körber C; Luster M; Rendl J; Reiners C; Köhrle J
Endocr Regul; 2004 Jun; 38(2):41-9. PubMed ID: 15497927
[TBL] [Abstract][Full Text] [Related]
33. [Influence of endogenous TgAb upon serum Tg measurement results and Tg positive rate in patients with differentiated thyroid carcinoma].
Zhang W; Deng H; Pan M; Huang R; Tang G
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2013 Aug; 30(4):803-7. PubMed ID: 24059060
[TBL] [Abstract][Full Text] [Related]
34. Recombinant thyroid-stimulating hormone in differentiated thyroid cancer.
Krausz Y; Uziely B; Nesher R; Chisin R; Glaser B
Isr Med Assoc J; 2001 Nov; 3(11):843-9. PubMed ID: 11729583
[TBL] [Abstract][Full Text] [Related]
35. Thyroglobulin antibody (TgAb) methods - Strengths, pitfalls and clinical utility for monitoring TgAb-positive patients with differentiated thyroid cancer.
Spencer C; Fatemi S
Best Pract Res Clin Endocrinol Metab; 2013 Oct; 27(5):701-12. PubMed ID: 24094640
[TBL] [Abstract][Full Text] [Related]
36. Clinical experience with recombinant human thyroid-stimulating hormone (rhTSH): serum thyroglobulin measurement.
Pacini F; Lippi F
J Endocrinol Invest; 1999; 22(11 Suppl):25-9. PubMed ID: 10727002
[TBL] [Abstract][Full Text] [Related]
37. Value of stimulated serum thyroglobulin levels for detecting persistent or recurrent differentiated thyroid cancer in high- and low-risk patients.
Duren M; Siperstein AE; Shen W; Duh QY; Morita E; Clark OH
Surgery; 1999 Jul; 126(1):13-9. PubMed ID: 10418587
[TBL] [Abstract][Full Text] [Related]
38. [The value of a new IRMA for determining thyroglobulin].
Heinze HG; Rall M
Nuklearmedizin; 1992 Oct; 31(5):172-7. PubMed ID: 1465354
[TBL] [Abstract][Full Text] [Related]
39. Clinical laboratory verification of thyroglobulin concentrations in the presence of autoantibodies to thyroglobulin: comparison of EIA, radioimmunoassay and LC MS/MS measurements in an Urban Hospital.
Wheeler SE; Liu L; Blair HC; Sivak R; Longo N; Tischler J; Mulvey K; Palmer OMP
BMC Res Notes; 2017 Dec; 10(1):725. PubMed ID: 29221487
[TBL] [Abstract][Full Text] [Related]
40. Serum thyroglobulin in the monitoring of differentiated thyroid cancer.
Evans C; Tennant S; Perros P
Scand J Clin Lab Invest Suppl; 2016; 245():S119-23. PubMed ID: 27542000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]